Study of VX-770 in Subjects With Moderate Hepatic Impairment and in Matched Healthy Subjects

Clinical trial NCT01208285 · COMPLETED

Trial details

NCT number: NCT01208285
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

In Development for Cystic Fibrosis

Start date: 2010-09-01
Primary completion: 2010-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.